Stay updated on InMed Pharmaceuticals Press Releases

Sign up to get notified when there's something new on the InMed Pharmaceuticals Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the InMed Pharmaceuticals Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added two new press releases: 'InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies' (May 19, 2026) and 'InMed Pharmaceuticals Amends Preferred Investment Options'. Removed two older items: 'InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules' (June 25, 2025) and 'InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study' (June 24, 2025).
    Difference
    7%
    Check dated 2026-05-22T16:13:12.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new May 6, 2026 press release entry announcing InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update was added to the Press Releases list. An older June 13, 2025 entry about CBIZ auditor appointment and related actions was removed.
    Difference
    1%
    Check dated 2026-05-08T11:11:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new press release entry dated April 27, 2026, InMed Pharmaceuticals Amends Preferred Investment Options, has been added to the press releases page, while the May 12, 2025 entry InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update has been removed. This updates the investor news archive to reflect new corporate actions and a revised historical listing.
    Difference
    1%
    Check dated 2026-05-01T08:11:35.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Added a March 27, 2026 press release about Nasdaq notification regarding minimum bid price compliance. Removed the February 12, 2025 press release InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update from the listing.
    Difference
    1%
    Check dated 2026-04-02T15:14:45.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a March 23, 2026 press release about INM-901 neuroinflammation data; removed the February 3, 2025 press release on INM-089 for age-related macular degeneration.
    Difference
    1%
    Check dated 2026-03-26T11:19:37.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added March 6, 2026 and March 9, 2026 press releases detailing BayMedica operations and advancement toward IND/clinical trials, plus webinars on Alzheimer’s Outlook and the evolving disease landscape. Removed older manufacturing-related items and product-specific content.
    Difference
    5%
    Check dated 2026-03-11T20:07:52.000Z thumbnail image

Stay in the know with updates to InMed Pharmaceuticals Press Releases

Enter your email address, and we'll notify you when there's something new on the InMed Pharmaceuticals Press Releases page.